Stefania Niakarou Simou - Greece | Professional Profile | LinkedIn
Hello world! - Simos Food Group
Journal of Autoimmunity | Vol 84, Pages 1-132 (November 2017) | ScienceDirect.com by Elsevier
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text
C-view Apartments & Maisonettes, Agistri Island | Angístri
Overview of the HMA-EMA Big Data Taskforce priority 3: recommendation to enable data discoverability
Stefania Moisidou - Greece Psychotherapeutic intervention in bipolar disorder A review - Conflix
C-view Apartments & Maisonettes, Agistri Island | Angístri
Stefania Niakarou Simou - Greece | Professional Profile | LinkedIn
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling - Deakin - 2018 - Arthritis & Rheumatology - Wiley Online Library
Stefania Simou's research works | Great Ormond Street Hospital for Children NHS Foundation Trust, London (GOSH) and other places
Biostatistics Training Curriculum
Stefania Simou - Healthcare Data Analyst - European Medicines Agency | LinkedIn
Stefania Niakarou Simou - Greece | Professional Profile | LinkedIn
Stefania Simou - Healthcare Data Analyst - European Medicines Agency | LinkedIn
Simou - Names Encyclopedia
Greece's Most Inspiring Female Entrepreneurs
Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Pati
STUDENT AWARDS CEREMONY 2014
Biostatistics Training Curriculum
Breakout session 4_G.Candore_S.Simou - Training and expertise
Stefania Niakarou Simou | Qrator
Stefania Niakarou Simou - Greece | Professional Profile | LinkedIn
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients | Arthritis Research & Therapy | Full Text
Stefania Simou - Healthcare Data Analyst - European Medicines Agency | LinkedIn
Stefania Simou - Healthcare Data Analyst - European Medicines Agency | LinkedIn